chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt to hospital on 10/17/22 with generalized weakness and AMS; found to be positive for COVID; O2 supplementation; Remdesivir; Dexamethasone, empirical antibiotics; ICU; pt experienced non-sustained ventricular tachycardia; treated with medication; pt's condition deteriorated; transitioned to comfort measures, and he passed away in the hospital
About 2-3 days later upper left arm very sore,red, & swollen in 3 inch X 3 inch area.  No fever or other Sx.  It hurt too much to lie on it.  Public Health Nurse notified by patient on 10/19/06 and examined left arm with quarter size round erythemic, tender & warm to touch area with a darker dime size area in the center.  Patient's daughter reports today 10/21/06 by phone that soreness & redness is resolving.
Initial report received from a parent of a patient on 16 June 2007. A 7 year old male patient (with no known allergies) developed hives on his face, neck, arms and lower back, 3 1/2 to 4 hours after is received Adacel (lot number unknown intramuscularly in the left deltoid on 15 June 2007. He was treated with Benadryl and it resolved. He also complained of pain and swelling in the left arm and pain from the left clavicle extending to the right clavicle. He also complained of pins and needles in the "LLE" radiating from the hip. The patient did not have any illness and was not on any medications at the time of the vaccination. At the time of the report, he had not recovered.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE DRUG INDUCED POLYNEUROPATHY POLYNEUROPATHY HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/14/2022 --  RECURRENCE OF SAME SYMPTOMS
sore arm; headache; vomiting; Red arm; Itchy arm; Arm very swollen; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), HEADACHE (headache), VOMITING (vomiting), VACCINATION SITE ERYTHEMA (Red arm) and VACCINATION SITE PRURITUS (Itchy arm) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (Historical  condition not reported.). Concomitant products included MULTIVITAMINS [VITAMINS NOS] and MINERALS NOS, VITAMINS NOS (CENTRUM A TO ZINC).    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red arm), VACCINATION SITE PRURITUS (Itchy arm) and VACCINATION SITE SWELLING (Arm very swollen). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), HEADACHE (headache) and VOMITING (vomiting). At the time of the report, PAIN IN EXTREMITY (sore arm), HEADACHE (headache) and VOMITING (vomiting) outcome was unknown and VACCINATION SITE ERYTHEMA (Red arm), VACCINATION SITE PRURITUS (Itchy arm) and VACCINATION SITE SWELLING (Arm very swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Ct c/o feeling of throat tightening up and difficulty breathing approx 3 1/2-4 hrs of receiving vaccinations.  Went to bed and next am awake with throat tightness and breathing trouble, but left eye was swollen shut, right eye puffy, hands and arms swollen bilat., temp 100.9, earlobes also swollen, rash with red blotchness right hand. No local reaction, no arthralgia, ct saw pcp on 2/27/07.  Treated with Benadryl 50mg a 6 hour x 2-3 days. Improved substantially by 3/27
Patient received Menactra and Tdap - started having sore arms that night, then next day.  Low grade fever, chills.  Also pain, fatigue.
The day after vaccination the patient developed a rash on left side of face (same side as she received the vaccine.) Rash initially spread, but has slowly dissipated over the course of 10 days. Rash on check was size of a dime, had multiple elongated spots appear on eyebrow (roughly 2 inches long) and on the chin (roughly 2.5in long.)
first dose Pfizer vaccine, second dose Moderna COVID-19 vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (first dose Pfizer vaccine, second dose Moderna COVID-19 vaccine) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (first dose Pfizer vaccine, second dose Moderna COVID-19 vaccine). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (first dose Pfizer vaccine, second dose Moderna COVID-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Information has been received from a physician's assistant concerning a 16 year old female who on 16-SEP-2008 was vaccinated with a dose of GARDASIL (lot # 660618/0572X) into the left deltoid.  On 17-SEP-2008 the patient developed a rash on her groin and hives over the rest of her body.  She also reported swollen lymph nodes in her left axillary area.  She was treated topical steroids and antibiotics.  No other information was available.
The same day as receiving the combo booster shot, his arm around the site got very warm, Hard to the touch and he aid it hurt.  It was a large red rash which he still has 2 weeks later.
Allergies turned into sinus infection; This spontaneous case was reported by a patient and describes the occurrence of ALLERGIC SINUSITIS (Allergies turned into sinus infection) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient started UPADACITINIB (RINVOQ) (Oral) at an unspecified dose. On 14-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In May 2022, the patient experienced ALLERGIC SINUSITIS (Allergies turned into sinus infection). In May 2022, ALLERGIC SINUSITIS (Allergies turned into sinus infection) had resolved.            No Concomitant medication was reported.  It was unknown if patient was enrolled in a COVID-19 vaccine trial.  The treatment information was patient went on antibiotics.
Within 30 minutes: nausea, managed with ginger At 1 hour: left hand pain, moderate-to-severe, went away Next day morning, afternoon, and evening: nausea continued, lack of appetite, mild-to-moderate headache, joint and muscle pain Next day around dinner time: chills to the point of chattering, fever up to 103.6, dizziness, difficulty walking due to pain and dizziness  At 6:22 p.m. on 9/21/21 experienced in addition to above symptoms: left-sided chest pressure/pain, cold sweats, slight shortness of breath, numbness in bilateral fingers. Took a 325 mg aspirin at 6:24 pm. Chest pain started getting better after about 5 minutes, within an hour many of the symptoms were better. At bedtime (around 10 or 11 pm, I do not remember the exact time), my adult daughter was hesitant to go to bed because she said that I looked so ill, even though I felt better than before. She said that my face was drained of color. Felt much better the next day. Since then I have experienced intermittent chest pain not accompanied by other symptoms, which resolves with aspirin. And oddly, my upper right arm has hurt intermittently (but I received the shot in my left arm). But symptoms other than the chest and arm pain appear resolved completely.
Hives (red spots) on right arm; Hives on neck (two spots); Itchy hives; Sore arm; Headache; Body Aches; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives (red spots) on right arm), URTICARIA (Hives on neck (two spots)), PAIN (Body Aches), PRURITUS (Itchy hives) and PAIN IN EXTREMITY (Sore arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN (Body Aches), PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache). On an unknown date, the patient experienced URTICARIA (Hives (red spots) on right arm), URTICARIA (Hives on neck (two spots)) and PRURITUS (Itchy hives). On 24-Mar-2021, PAIN (Body Aches), PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache) had resolved. At the time of the report, URTICARIA (Hives (red spots) on right arm), URTICARIA (Hives on neck (two spots)) and PRURITUS (Itchy hives) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment information was not provided. concomitant drug information does not provided.
The patient said she "had mental problems."  She didn't know who she was or where she was for about a day and a half.
2 different antibody tests and both test showed 0 antibodies for the COVID19 virus; lymphocyte counts were at 0.40 and now it was down to 0.24; This is a spontaneous report. A contactable 67-year-old female consumer (patient) reported for herself that:  The 67-years-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE and dose 2 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for COVID-19 immunization. The patient had medical history of multiple sclerosis for which patient was taking Gilenya. The concomitant medications were not reported. Patient reported that she took 2 different antibody tests and both tests showed 0 antibodies for the COVID 19 virus. She also reported that prior getting the vaccine her lymphocyte counts were at 0.40 and now it was down to 0.24. The outcome of the event was unknown.   Information on the lot/batch number has been requested.
Onset of significant muscle and joint aches, fatigue, shivering, flushing (no fever) and mild nausea approx 12 hours after injection lasting through the next day with diminishing severity over first 24 hours after injection.  Site swelling, redness and warmth developed the next day and persisted for approx. 2 days.   Mild headache, mild fatigue and sore ear and throat present on day 6 after injection.  Now at day 6 all symptoms are largely resolved, residual is minimal.
Immediately following the injection, felt "spacey." He went home to rest and developed a headache. Symptoms seemed to subside until the evening of April 1. He woke up from a nap with chills and had a 100.9 fever. The fever has subsided but for 6 days he has had a headache, body aches, fatigue and nausea. The morning of April 8, he has vomited.
soreness to his arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program.  A male patient received bnt162b2 (BNT162B2), administration date 15Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "back pain" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "soreness to his arm". Additional information: the reporter was asking if the patient can take Tylenol or Ibuprofen for his back pain and if there is an amount of time that the patient has to wait before or after having his second vaccine dose to get a spinal block. The reporter stated that the patient has a history of back pain and received his first Pfizer Covid vaccine dose on 15Mar2021 and will be due for his second dose on 05Apr2021. The patient has had back issues for several years, and has received spinal injections and is due for a different spinal block on 25Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Narrative: COVID infection following COVID vaccine series 02/25, Pfizer, dose #1 03/18, Pfizer, dose #2 06/01 CXR impression: Chronic scarring and platelike atelectasis at the lung bases on background of COPD without evidence for active pulmonary process. 08/16 pt cc: cough, chills, fatigue, fever, headache, loss of taste or smell, myalgias, rhonorrhea, dyspnea exposure: unknown 08/16 COVID swab, result: detected 08/17 -08/20 pt symptoms continue
headache; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of HEADACHE (headache) and CHILLS (chills) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache) and CHILLS (chills). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) for Adverse event, at a dose of UNK dosage form. At the time of the report, HEADACHE (headache) and CHILLS (chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Rash on the back, itching, Benadryl 25mg cap 1-2 Q6H for allergy PRN or itching, ZYRTEC 10 MG 1 TAB PO QD, Acyclovir 400mg oral tab. 1 po TID x 5 days.
8 days p/vax devel a fever of 104 followed by maculopapular rash all over body;no vesicles;rash lasted 5 days, fever lasted 4 days;very sick per foster mom;
Information has been received from an approximately 67 year old male consumer with a history of stent in heart 12 years ago with no drug reactions or allergies concerning himself who in approximately 2009 ("about 3 years prior") was vaccinated with a dose of ZOSTAVAX (Merck) (dose, route and lot # not reported). Concomitant therapy included unspecified pain medication. In October 2011, the patient had some teeth extracted and after that developed a rash on his face that got worse. The patient went to the emergency room where it was diagnosed as dermatitis, but 2 days later it was diagnosed as shingles, although he had had the ZOSTAVAX (Merck) vaccine about 3 years prior. From that he developed Ramsay Hunt Syndrome that was diagnosed by an ear doctor. The patient still had pain. The patient was given ointment and pain medications. Blood test was performed (results not reported). At the time of the report, the patient did not recover. Follow up information was received from a health care professional reporting that the approximately 67 year old male patient "3 to 4 years ago" in approximately 2009 was vaccinated with a dose of ZOSTAVAX (dose, route and lot number not reported). It was reported that the patient developed shingles 3-4 years after getting ZOSTAVAX vaccine. No adverse reactions were reported. Additional information has been requested.
complaints: mild Tingling and burning sensation at the injection site. Denies chest pain, SOB, and itching No rash or erythema seen,  No acute distress Seen and cleared by  NP
DIFFICULTY SLEEPING; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 27-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 2021, the subject experienced difficulty sleeping. On 2021, the subject experienced injection site pain. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the injection site pain and difficulty sleeping was not reported. This report was non-serious.
Pregnant; Drop from syringe/related to type of syringe; Few drops of the vaccine dripped out of the syringe/few drips of vaccine drip down my arm/whoops some dripped.; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant), DEVICE CONNECTION ISSUE (Drop from syringe/related to type of syringe) and UNDERDOSE (Few drops of the vaccine dripped out of the syringe/few drips of vaccine drip down my arm/whoops some dripped.) in a 33-year-old female patient (gravida 4, para 3) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 030A21A) for COVID-19 vaccination.     Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from November 2020 to an unknown date for Pregnancy.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 27-Jul-2021. On 31-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant), DEVICE CONNECTION ISSUE (Drop from syringe/related to type of syringe) and UNDERDOSE (Few drops of the vaccine dripped out of the syringe/few drips of vaccine drip down my arm/whoops some dripped.). On 31-Mar-2021, DEVICE CONNECTION ISSUE (Drop from syringe/related to type of syringe) and UNDERDOSE (Few drops of the vaccine dripped out of the syringe/few drips of vaccine drip down my arm/whoops some dripped.) had resolved. At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2021, Ultrasound scan: normal (normal) Normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was unknown.  Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: Follow-up information received on 11-Jun-2021, updated vaccine facility name, patient height and event description.
Days 3, 4, 5, 6: Inability to move head in any direction (up/down or L/R) without SEVERE pain. Neck unable to support head unless directly above shoulders. Leaning forward slightly to sit or stand up caused unbearable pain. Unable to lift head from pillow to roll over. Could only swallow food, if neck muscles held tightly with hand to prevent movement. Severe pain caused Vasovagal syndrome fainting. Asymptomatic fever  99.7-100.5 for Days 3, 4, 5. No chills, weakness or aching.  Day 7: In A.M., slightly increased head movement possible for first time without pain. By P.M. even better, but still only very limited movement of a few inches possible. Improved daily thereafter. Day 15 (today): Mild stiff neck persists.
1 day p/vax pt devel an inject site rxn characterized by redness, warmth, & swelling;this is one of three employees from this site to devel an inj site rxn p/flu vax;
Patient reports severe pain in arm. She says she cannot lift up her stockings. This has been going on for 2 weeks since vaccination.
nov-88 and dec-88 pt vax hepta B.  aft each vax pt devel flulike sx.  may-89 pt 3rd vax. pt ex myalgia, and arthralgia at inject site and arthralgias at proximal interphalangeal joints of both hands.  See worm...
Patient C/O shortness of Breath and cramping in lower extremities on 4/14/21.   She was sent to local ER for evaluation and was admitted for observation.
Patient reported a "light head" and seeing stars directly after injection. We kept her at the pharmacy for 30 minutes to evaluate and checked her blood pressure. BP was 160/70 (patient reports that to be about normal for her). No other problems while waiting at the pharmacy. We called the patient back at 4:55PM to check on her; she states that she is fine.
She had moderna for 1 and 2. Had pfizer for her booster on 10/29.  Had low grade fever and achiness the day after. 17 hours later developed light headed, felt like she was going to pass out. Had some nausea. Felt like her blood pressure was really low. Checked her blood pressure a while later and her blood pressure was 96/64 - doesn't remember pulse.  O2 was 96% and thinks pulse was in 80's on oximeter.  She then fell immediately asleep and woke up 1.5 hours later and then felt much better.
Hair thinning/receding/loss on head, first noticed around 7/16/2021. Not sure whether or not it?s related to the covid vaccine, but am reporting it just in case it is. Have read and heard of other people with similar issue.
Vaccinated at a location on 5/17/2021, staff mentioned her obituary June 24th, 2021 and was concerned of her death so close to her vaccination date.
Patient reported tingling in her right fingers but reported to Heather that she was fine  as of 3:06pm
Second dose of the Moderna COVID-19 vaccine was expired 5 days; Chills; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Second dose of the Moderna COVID-19 vaccine was expired 5 days) and CHILLS (Chills) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Second dose of the Moderna COVID-19 vaccine was expired 5 days) and CHILLS (Chills). On 30-Apr-2021, EXPIRED PRODUCT ADMINISTERED (Second dose of the Moderna COVID-19 vaccine was expired 5 days) had resolved. At the time of the report, CHILLS (Chills) outcome was unknown.            Relevant concomitant product usage were not reported by the reporter. No treatment details were added. Action taken with mRNA-1273 in response to the event was not applicable.
Initial case received from a health care professional on 10 February 2011. The reporter identified 1 male patient, in addition to a cluster of "several patients", who experienced adverse events after receiving FLUZONE. A male patient in his 60's, and "several" other unidentified patients, received FLUZONE (unspecified, lot not reported) and subsequently tested positive for influenza. No additional information was reported. Documents held by sender: None.
Facial flushing and sensed diffuse itching. No hives or rash. Treated with one dose of diphenhydramine (reaction consistent with response to allergy shots, and treatment chosen was usual treatment for those occurences) with no recurrence.
Redness, swelling, fever, tenderness (R) arm. Lethargic. Had myelogram on 3-12-12 AM.